|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 显示文摘 | Pacini F Castagna MG Brilli L | 2010 | Ann Oncol2010，21，5： | 1 |
| 2 | Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up 显示文摘 | Pacini F Castagna MG Brilli L | 2009 | Ann Oncol2009，20，4： | 1 |
| 3 | Thyroid cancer: ESMOClinical Practice Guidelines for diagnosis,treatment and follow- up显示文摘 | Pacini F Castagna MG Brilli L | 2012 | Annals of Oncology2012，23，7： | 1 |
| 4 | Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 显示文摘 | Pacini F Castagna MG Brilli L | 2012 | Ann Oncol2012，23，7： | 1 |
| 5 | Ablation of thyroid residues with 30 mCi (131)I:a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal显示文摘 | Pacini F Molinaro E Castagna MG | 2002 | J Clin Endocrinol Metab2002，87，9： | 1 |
| 6 | Approach to and treatment of differentiated thyroid carcinoma 显示文摘 | Pacini F Castagna MG | 2012 | Med Clin North Am2012，96，： | 1 |
| 7 | Nodules in autoim- mune thyroiditis are associated with increased risk of thyroid canc- er in surgical series but not in cytological series: evidence for se- lection bias 显示文摘 | Castagna MG Belardini V Memmo S | 2014 | J Clin Endocrinol Metab2014，99，9： | 1 |
| 8 | Thyroid cancer:ESMO Clinical Practice Guidelines for diagnosis,treat-ment and follow-up显示文摘 | Pacini F Castagna MG Brilli L | 2010 | Ann Oncol2010，21，5： | 1 |
| 9 | Approach to and treatment of differentiated thyroid carcinoma 显示文摘 | Pacini F Castagna MG | 2012 | Med Clin North Am2012，96，2： | 1 |
| 10 | Thyroid cancer:ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 显示文摘 | Pacini F Castagna MG Bfilli L | 2010 | Ann Oncology2010，21，5： | 1 |
| 11 | Recombinant human thyrotropinstimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma显示文摘 | Pacini F Molinaro E Castagna MG | 2003 | J Clin Endocrinol Metab2003，88，8： | 1 |
| 12 | Differentiated thyroid cancer:ESMO clinical recommendations for diagnosis,treatment and follow-up显示文摘 | Pacini F Castagna MG Brilli L | 2009 | Ann Oncol2009，204，： | 1 |
| 13 | Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients显示文摘 | Castagna MG Maino F Cipri C | 2011 | Eur J Endocrinol2011，165，： | 1 |
| 14 | Thyroid cancer: ESMO clinical practice guidelines fordiagnosis, treatment and follow-up显示文摘 | Pacini F Castagna MG Pentheroudakis LBG | 2010 | Ann Oncol2010，21，5： | 1 |
| 15 | Medullary thyroid carcinoma 显示文摘 | Pacini F Castagna MG Cipri C | 2010 | Clin Oncol ( R Coil Radlol)2010，22，： | 1 |
| 16 | The use of ultrasensi- tivc thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma 显示文摘 | Castagna MG Tala Jury HP Cipri C | 2011 | J Endocrinol Invest2011，34，8： | 1 |
| 17 | Medullary thyroid carcinoma显示文摘 | Pacini F Castagna MG Cipri C | 2010 | Clin Oncol (R Coil Radiol)2010，22，6： | 1 |
| 18 | Thyroid cancer:ESMO clinical practice guidelines fordiagnosis,treatment snd follow-up显示文摘 | Pacini F Castagna MG Pentheroudarkis LBG | | 0，，5： | 1 |
| 19 | Delayed risk strati-fication,to include the response to initial treatment(surgery and radioiodine ablation),has better outcomepredictivity in differentiated thyroid cancer patients 显示文摘 | Castagna MG Maino F Cipri C | 2011 | Eur J Endocrinol2011，165，3： | 1 |
| 20 | Differentiated thyroid cancer:ESMO clinical recommendations for diagnosis,treatment and follow-up显示文摘 | Pacini F Castagna MG Brilli L | 2009 | Ann Oncol2009，20，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员